Shahram Seyedin-Noor, Civilization Ventures
August 25, 2020 10:42 AM EDT
People
Financing

A small VC group ex­pands its hunt for in­spired biotech founders in need of seed cash

Max Gelman

Senior Editor

Civ­i­liza­tion Ven­tures, a Cal­i­for­nia-based VC fund that suc­cess­ful­ly bet on biotechs Rock­et Phar­ma­ceu­ti­cals and Sin­gu­lar Bio a few years ago, is bring­ing forth its next …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

WuXi AppTec will sell cell and gene ther­a­py busi­ness to pri­vate eq­ui­ty firm

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times